false
0001864531
0001864531
2024-07-24
2024-07-24
0001864531
us-gaap:CommonStockMember
2024-07-24
2024-07-24
0001864531
us-gaap:WarrantMember
2024-07-24
2024-07-24
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
July 24, 2024
VSEE
HEALTH, INC.
(Exact name of registrant as specified in its charter)
Delaware |
|
001-41015 |
|
86-2970927 |
(State or other jurisdiction of incorporation) |
|
(Commission
File Number) |
|
(I.R.S. Employer Identification No.) |
980 N Federal Hwy #304
Boca Raton, Florida |
|
33432 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: (754) 231-1688
N/A
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class |
|
Trading
Symbol |
|
Name of each exchange
on
which registered |
Common Stock, $0.0001 par value per share |
|
VSEE |
|
The Nasdaq Stock Market LLC |
Warrants,
which entitles the holder to purchase one (1) share of common stock at a price of $11.50 per whole share |
|
VSEEW |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933(§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth
company x
If an emerging growth
company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 7.01. Regulation FD Disclosure.
On July 24, 2024, VSee Health, Inc.
(the “Company”) issued a press release announcing that the Company has partnered with SkywardRx, a digital healthcare services
and consulting firm, to provide telehealth and billing services to SkywardRx’s nonprofit, hospital and Fortune 20 corporate clients.
A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated herein by reference.
The information included in this Item 7.01
and Exhibit 99.1 of this Current Report on Form 8-K is not deemed to be “filed” for purposes of Section 18
of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall this item and Exhibit 99.1 be incorporated
by reference into the Company’s filings under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set
forth by specific reference in such future filing.
Item 9.01. Financial Statement and Exhibits.
(c) Exhibits.
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned
hereunto duly authorized.
Dated: July 29, 2024 |
VSEE HEALTH, INC. |
|
|
|
|
By: |
/s/ Imoigele Aisiku |
|
Name: |
Imoigele Aisiku |
|
Title: |
Co-Chief Executive Officer |
Exhibit 99.1
VSee Health to Provide Telehealth and Billing
Services to SkywardRx Clients
SAN JOSE, Calif., July 24, 2024 -- VSee Health, Inc.
(NASDAQ: VSEE), a provider of comprehensive telehealth services that customize telehealth workflow streams, enhance patient care and turnkey
billing services, announces it has partnered with SkywardRx, a digital healthcare services and consulting firm, to provide telehealth
and billing services to SkywardRx’s nonprofit, hospital and Fortune 20 corporate clients. This partnership allows both organizations
to expand their shared commitment of optimizing patient access within critical areas of healthcare delivery including behavioral health,
nutritional wellness and substance abuse, while reducing overall healthcare cost for both the patient and provider.
"This new partnership is an important step
in our mission to improve healthcare delivery and access for the most vulnerable patient populations," said Imo Aisiku, M.D., co-CEO
and Chairman of VSee Health. "By combining VSee’s turnkey technology and billing services with SkywardRx’s personal consulting
services, we have the opportunity to advance our commitment of optimizing the patient experience and reducing healthcare costs for both
patients and healthcare providers. This partnership has the potential to expand our services to the approximately five million patients
served by SkywardRx and their clients."
"We are incredibly excited to partner with
VSee Health, bringing together the best in healthcare technology and patient engagement," said Dave Rike, co-Founder and CRO of SkywardRx.
"VSee Health’s billing and telehealth services are a critical component in delivering better health outcomes to our clients.
Our customer base includes national nonprofits, health systems, employer groups and individuals looking to save money and improve their
health."
About VSee Health
VSee Health is a software-as-a-service (SaaS)
platform that enables clinicians and enterprises to create their telehealth workflows without programming. VSee Health’s system
allows a telehealth mobile app to be created or a telehealth system to be integrated into existing hospital operations in days.
With a focus on patient disease state telemedicine
and turnkey billing services, VSee Health has integrated an intensive care, critical care and neuro solution, powered by iDoc Telehealth
Solutions, as its initial module for the VSee Health software platform. This technology encompasses a set of integrated telehealth technologies
and a team of neurointensivists, neurologists, tele-radiologists that treat and coordinate care for acutely ill patients 24/7/365 in the
neurointensive care unit (Neuro-ICU), cardiac surgery intensive care unit (CS-ICU) and the intensive care unit (ICU) for stroke, brain
trauma and a wide range of neurological conditions. For more information, please visit www.vseehealth.com.
About SkywardRx
SkywardRx stands as a leading healthcare consulting
firm with a distinguished track record of collaboration with non-profits, hospitals, and Fortune 20 companies. Co-founders Dave Rike and
Alex Whitacre, both industry stalwarts with over 30 years of combined healthcare experience, bring a wealth of knowledge and success,
having successfully built various healthcare enterprises throughout their careers. Their commitment to driving positive change in the
healthcare landscape stands as the cornerstone of SkywardRx's mission. Learn more at www.skywardrx.com.
Forward-Looking Statements
Matters discussed in this release that are not
statements of historical or current facts, including but not limited to those relating to VSee Health’s ability to improve healthcare
access and Provider efficiencies, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform
Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause performance
or achievements to be materially different from historical results or from any future performance or achievements expressed or implied
by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. More information
on risk factors relating to VSee and its technology and billing services is included from time to time in the "Cautionary Note Regarding
Forward-Looking Statements," "Risk Factors" and "Management’s Discussion and Analysis of Financial Condition
and Results of Operations" sections of VSee’s periodic and current filings with the SEC, which are also made available on VSee’s
website at www.vseehealth.com. Forward-looking statements speak only as of the date they are made, and VSee undertakes no obligation to
publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur
after that date, or otherwise.
Contacts
LHA Investor Relations
Tirth T. Patel
212-201-6614
tpatel@lhai.com
v3.24.2
Cover
|
Jul. 24, 2024 |
Document Type |
8-K
|
Amendment Flag |
false
|
Document Period End Date |
Jul. 24, 2024
|
Entity File Number |
001-41015
|
Entity Registrant Name |
VSEE
HEALTH, INC.
|
Entity Central Index Key |
0001864531
|
Entity Tax Identification Number |
86-2970927
|
Entity Incorporation, State or Country Code |
DE
|
Entity Address, Address Line One |
980 N Federal Hwy #304
|
Entity Address, City or Town |
Boca Raton
|
Entity Address, State or Province |
FL
|
Entity Address, Postal Zip Code |
33432
|
City Area Code |
754
|
Local Phone Number |
231-1688
|
Written Communications |
false
|
Soliciting Material |
false
|
Pre-commencement Tender Offer |
false
|
Pre-commencement Issuer Tender Offer |
false
|
Entity Emerging Growth Company |
true
|
Elected Not To Use the Extended Transition Period |
false
|
Common Stock [Member] |
|
Title of 12(b) Security |
Common Stock, $0.0001 par value per share
|
Trading Symbol |
VSEE
|
Security Exchange Name |
NASDAQ
|
Warrant [Member] |
|
Title of 12(b) Security |
Warrants,
which entitles the holder to purchase one (1) share of common stock at a price of $11.50 per whole share
|
Trading Symbol |
VSEEW
|
Security Exchange Name |
NASDAQ
|
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
VSee Health (NASDAQ:VSEE)
과거 데이터 주식 차트
부터 9월(9) 2024 으로 10월(10) 2024
VSee Health (NASDAQ:VSEE)
과거 데이터 주식 차트
부터 10월(10) 2023 으로 10월(10) 2024